跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Raphzep - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Raphzep
Approved
STANDARD
Raphzep
Azarias Pharmaceutical Laboratories
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4edc343f0060c36b
Company
Azarias Pharmaceutical Laboratories
Type
Standard
Approval Details
Approval Id
4edc343f0060c36b
Drug Approval Philippines Name
Raphzep
Product Name
Raphzep
Registration Number
DRP-4997
Brand Name
Raphzep
Generic Name
Paracetamol + Phenylephrine Hydrochloride + Chlorpheniramine Maleate
Dosage Form
Tablet
Dosage Strength
500 mg/10 mg/2 mg
Manufacturer
Azarias Pharmaceutical Laboratories
Distributor
St. Raphael, The Archangel Pharmaceutical Distributor
Issuance Date
29 December 2023
Expiry Date
09 December 2028
Pharmacologic Category
Analgesic/Antipyretics/Sympathomimetics
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4edc343f0060c36b
Type
Standard
Back to Philippines FDA Approvals